When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel-Reference-Cited by-同舟云学术

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel

Published:2013-11 Issue:10 Volume:7 Page:820-826
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Pittet Valerie,Froehlich Florian,Maillard Michel H.,Mottet Christian,Gonvers Jean-Jacques,Felley Christian,Vader John-Paul,Burnand Bernard,Michetti Pierre,Schoepfer Alain

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/7/10/820/1077206/7-10-820.pdf

Reference37 articles.

1. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease;Prefontaine;Cochrane Database Syst Rev,2009

2. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease;Hindorf;Aliment Pharmacol Ther,2009

3. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators;Feagan;N Engl J Med,2000

4. Infliximab, azathioprine, or combination therapy for Crohn's disease;Colombel;N Engl J Med,2010

5. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with ulcerative colitis who have normalized histology are clinically stable after de-escalation of therapy;npj Gut and Liver;2024-08-02

2. Putting patients at the centre of clinical decision making: BSGNA update;Gastrointestinal Nursing;2023-10-02

3. Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors;World Journal of Clinical Cases;2023-04-26

4. Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents;Crohn's & Colitis 360;2022-06-16

5. Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review;Cureus;2022-05-10